MAIA Biotechnologys Telomere Targeting Functionality Enhances Cancer Treatment
In recent years, MAIA Biotechnology, Inc. (NYSE American: MAIA) has emerged as a leading player in the field of targeted immunotherapies for cancer. With a focus on telomere-targeting functionality, the company s ground...
Jun 28, 2024
• Major Pharmaceutical Preparations Industry
Stocks on the Move
Inc Inc Inc Inc Phase Date Achievements June Inc
